Alesia McKeown, PhD, of Roche Diagnostics discusses why pertussis is missed in children and adolescents and how PCR testing can help. Pertussis (whooping cough) is often regarded as a ...
With a multistate cyclosporiasis outbreak underway this summer, pediatric providers should maintain a low threshold to consider Cyclospora cayetanensis in children with protracted or relapsing watery ...
Later transfer to a cardiac surgical center was associated with longer hospitalization for newborns with severe congenital heart defects, Joyce Woo, MD, MS, explains. Joyce Woo, MD, MS, pediatric and ...
A look back at the FDA approvals, label expansions, and regulatory decisions in the pediatric health care space from April through June 2026. Spring gave way to summer, and along the way the FDA kept ...
RSV prevention shifts: maternal vaccines and nirsevimab protect infants when timed right, cutting hospitalizations and closing care gaps. Episode 12 addresses the practical question of which infants ...
Keep kids comfortable on summer trips with “fluid, fiber, flow”: smart hydration, fiber-forward snacks, movement breaks, and safe, half-packed meals to prevent constipation. It’s summertime, and that ...
The PANDAS/PANS questionnaire is based on symptoms and comorbidities described in the literature and is a self-report completed by parents of children younger than 18. "Bottom line, previous surgery ...
New AAP guidance recommends age-specific iron deficiency screening, updated ferritin thresholds, and simplified treatment strategies for children. Iron deficiency remains one of the most common ...
Risankizumab is now FDA approved for children 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis, with a new 55-mg syringe enabling weight-based dosing under 40 ...
THRIVE is the first study to evaluate the VIASKIN Peanut Patch in infants aged 6 to 12 months with confirmed peanut allergy. Investigators hope intervention during infancy may alter the long-term ...
This episode bridges the gap between clinical trial data and everyday practice, focusing on how pediatricians can systematically ensure no eligible infant falls through the cracks. This episode ...
Newborns without intramuscular vitamin K had an adjusted 52% higher odds of any bleeding and nearly 3-fold higher odds of intracranial hemorrhage by 6 months of age. Nonreceipt of intramuscular ...